Halozyme Therapeutics Inc. sell SVB Leerink LLC
Start price
13.05.25
/
50%
€48.64
Target price
13.05.26
€42.31
Performance (%)
22.49%
End price
14.05.26
€59.58
Summary
This prediction ended on 14.05.26 with a price of €59.58. The prediction closed with a disappointing performance of 22.49%. SVB_Leerink_LLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Halozyme Therapeutics Inc. | 24.336% | 24.336% | 64.630% |
| iShares Core DAX® | 1,00 % | 4,83 % | 8,15 % |
| iShares Nasdaq 100 | 2,70 % | -1,72 % | 26,92 % |
| iShares Nikkei 225® | 3,52 % | -3,51 % | 48,06 % |
| iShares S&P 500 | 1,77 % | 1,27 % | 23,58 % |
Comments by SVB_Leerink_LLC for this prediction
In the thread Halozyme Therapeutics Inc. diskutieren
Halozyme Therapeutics, Inc. (NASDAQ: HALO) was downgraded by analysts at Leerink Partners from a "market perform" rating to an "underperform" rating. They now have a $47.00 price target on the stock.
Ratings data for HALO provided by MarketBeat
In the thread Trading Halozyme Therapeutics Inc.
Die von SVB_Leerink_LLC gewählte maximale Laufzeit wurde überschritten